A study of the effectiveness of bilateral transcranial magnetic stimulation in the treatment of the negative symptoms of schizophrenia

Brain Stimulation

Volumn 1, Issue 1, 2008, Pages 27-32

  Fitzgerald, Paul B ^a   Herring, Sally ^c   Hoy, Kate ^a   McQueen, Susan ^a   Segrave, Rebecca ^a   Kulkarni, Jayashri ^a   Daskalakis, Zafiris J ^b  

^a MONASH UNIVERSITY   (Australia)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c NONE

Author keywords

prefrontal cortex; remission; repetitive transcranial magnetic stimulation; response; schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; AUTISM; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; SYMPTOMATOLOGY; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGICAL RATING SCALE; TREATMENT FAILURE;

ADULT; ANTIPSYCHOTIC AGENTS; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 45949097437     PISSN: 1935861X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brs.2007.08.001     Document Type: Article

References (35)

1. Berman R.M., Narasimhan M., Sanadora G., et al. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry 47 (2000) 332-337
2. George M.S., Nahas Z., Molloy M., et al. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry 48 (2000) 962-970
3. Fitzgerald P.B., Brown T.L., Marston N.A., et al. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 60 (2003) 1002-1008
4. Fitzgerald P.B., Benitez J., De Castella A.R., et al. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry 163 (2006) 88-94
5. Fitzgerald P.B., Benitez J., Daskalakis J.Z., et al. A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. J Clin Psychopharmacol 25 (2005) 358-362
6. Hoffman R.E., Gueorguieva R., Hawkins K.A., et al. Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry 58 (2005) 97-104
7. Hoffman R.E., Hawkins K.A., Gueorguieva R., et al. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry 60 (2003) 49-56
8. Cohen E., Bernardo M., Masana J., et al. Repetitive transcranial magnetic stimulation in the treatment of chronic negative schizophrenia: a pilot study. J Neurol Neurosurg Psychiatry 67 (1999) 129-130
9. Jandl M., Bittner R., Sack A., et al. Changes in negative symptoms and EEG in schizophrenic patients after repetitive transcranial magnetic stimulation (rTMS): an open-label pilot study. J Neural Transm 112 (2005) 955-967
10. Mogg A., Purvis R., Eranti S., et al. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study. Schizophr Res 93 (2007) 221-228
11. Novak T., Horacek J., Mohr P., et al. The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results. Neuro Endocrinol Lett 27 (2006) 209-213
12. Hajak G., Marienhagen J., Langguth B., et al. High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treatment and neuroimaging study. Psychol Med 34 (2004) 1157-1163
13. Holi M.M., Eronen M., Toivonen K., et al. Left prefrontal repetitive transcranial magnetic stimulation in schizophrenia. Schizophr Bull 30 (2004) 429-434
14. Addington D., Addington J., and Maticka-Tyndale E. Assessing depression in schizophrenia: the calgary depression scale. Br J Psychiatry Suppl (1993) 39-44
15. Jin Y., Potkin S.G., Kemp A.S., et al. Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (AlphaTMS) on the negative symptoms of schizophrenia. Schizophr Bull 32 (2006) 556-561
16. Klemm E., Danos P., Grunwald F., et al. Temporal lobe dysfunction and correlation of regional cerebral blood flow abnormalities with psychopathology in schizophrenia and major depression-a study with single photon emission computed tomography. Psychiatry Res 68 (1996) 1-10
17. Wolkin A., Sanfilipo M., Wolf A.P., et al. Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry 49 (1992) 959-965
18. Sabri O., Erkwoh R., Schreckenberger M., et al. Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics. J Nucl Med 38 (1997) 181-188
19. Spitzer R.L., Williams J.B.W., and Gibbon M. Structured clinical interview for DSM-IV (SCID) (1995), Biometrics Research, New York
20. Andreasen N.C. Scale for the assessment of negative symptoms (SANS) (1984), University of Iowa, Iowa city, IA
21. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13 (1987) 261-276
22. Kay S.R., Opler L.A., and Fiszbein A. Positive and negative syndrome scale (PANSS) (2000), Multi-Health Systems Inc, Toronto Canada
23. Golden C.J. Stroop color and word test (1978), Stoelting Company, Wood Dale IL
24. Spreen O., and Strauss E. A compendium of neuropsychological tests. 2nd ed. (1998), Oxford University Press, New York
25. Fitzgerald P.B., Brown T., Marston N.A.U., et al. Reduced plastic brain responses in schizophrenia: a transcranial magnetic stimulation study. Schizophr Res 71 (2004) 17-26
26. Oxley T., Fitzgerald P.B., Brown T.L., et al. Repetitive transcranial magnetic stimulation reveals abnormal plastic response to premotor cortex stimulation in schizophrenia. Biol Psychiatry 56 (2004) 628-633
27. Aleman A., Sommer I.E., and Kahn R.S. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J Clin Psychiatry 68 (2007) 416-421
28. Eyler L.T., Olsen R.K., Jeste D.V., and Brown G.G. Abnormal brain response of chronic schizophrenia patients despite normal performance during a visual vigilance task. Psychiatry Res 130 (2004) 245-257
29. Holmes A.J., MacDonald III A., Carter C.S., et al. Prefrontal functioning during context processing in schizophrenia and major depression: an event-related fMRI study. Schizophr Res 76 (2005) 199-206
30. Morey R.A., Inan S., Mitchell T.V., et al. Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Arch Gen Psychiatry 62 (2005) 254-262
31. Sanfilipo M., Lafargue T., Rusinek H., et al. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch Gen Psychiatry 57 (2000) 471-480
32. Kozel F.A., Nahas Z., deBrux C., et al. How coil-cortex distance relates to age, motor threshold, and antidepressant response to repetitive transcranial magnetic stimulation. J Neuropsychiatry Clin Neurosci 12 (2000) 376-384
33. McConnell K.A., Nahas Z., Shastri A., et al. The transcranial magnetic stimulation motor threshold depends on the distance from coil to underlying cortex: a replication in healthy adults comparing two methods of assessing the distance to cortex. Biol Psychiatry 49 (2001) 454-459
34. Stokes M.G., Chambers C.D., Gould I.C., et al. Simple metric for scaling motor threshold based on scalp-cortex distance: application to studies using transcranial magnetic stimulation. J Neurophysiol 94 (2005) 4520-4527
35. Storosum J.G., Elferink A.J., van Zwieten B.J., et al. Amisulpride: is there a treatment for negative symptoms in schizophrenia patients?. Schizophr Bull 28 (2002) 193-201